Ankara University, Faculty of Medicine, Dept. Pharmacology and Clinical Pharmacology and Molecular Biology and Technology Development Unit, Sihhiye, Ankara, Turkey.
Eur J Pharmacol. 2010 Mar 25;630(1-3):42-52. doi: 10.1016/j.ejphar.2009.12.035. Epub 2010 Jan 5.
Membrane rafts and caveolae are specialized microdomains of the cell membrane that form physical platforms for compartmentalization of signalling molecules. Here, we intended to gain insight into the consequences of caveolar localization in G protein-coupled receptor function. We analysed beta(2)-adrenoceptor signalling in purified CRLDF (caveolin-rich low density fractions) of beta(2)-adrenoceptor-overexpressing HEK-293 cells. beta(2)-adrenoceptor and Gs immunoreactivities and forskolin-stimulated adenylate cyclase activity were all detected in CRLDF obtained by the conventional raft purification method that uses Triton X-100 solubilization. However, Triton X-100 caused a complete loss of the functional coupling between beta(2)-adrenoceptor, Gs and adenylate cyclase. Therefore, we developed an optimized purification method based on n-octyl-beta-d-glucopyranoside solubilization, where the functional properties of beta(2)-adrenoceptor, Gs and adenylate cyclase were preserved in the CRLDF. Using this method, we showed that isoproterenol-stimulated adenylate cyclase activity was similar in CRLDF and bulk membrane preparations of HEK-293 cells that overexpress beta(2)-adrenoceptor or beta(2)-adrenoceptor-Gs fusion. Accordingly, treatment of cells with methyl-beta-cyclodextrin, a caveola-disrupting agent, did not affect beta(2)-adrenoceptor-induced cAMP response. Likewise, these responses were insensitive to caveolin 1 and 2 overexpression. On the other hand, methyl-beta-cyclodextrin treatment did decrease beta(2)-adrenoceptor-induced ERK phosphorylation. However, the latter effect of methyl-beta-cyclodextrin could be attributed to a non-specific effect rather than its ability to disrupt membrane microdomains. We showed that localization in the raft microdomains did not affect the signalling efficiency of beta(2)-adrenoceptor-Gs-adenylate cyclase pathway, and that methyl-beta-cyclodextrin may inhibit signalling by directly affecting the signalling system independently of its caveola-disrupting property.
膜筏和 caveolae 是细胞膜的特化微区,形成信号分子分隔的物理平台。在这里,我们旨在深入了解 caveolar 定位对 G 蛋白偶联受体功能的影响。我们分析了在过表达β 2-肾上腺素受体的 HEK-293 细胞中纯化的 CRLDF(富含 caveolin 的低密度级分)中的β 2-肾上腺素受体信号。通过使用 Triton X-100 溶解的传统筏纯化方法获得的 CRLDF 中均检测到β 2-肾上腺素受体和 Gs 的免疫反应性以及 forskolin 刺激的腺苷酸环化酶活性。然而,Triton X-100 导致β 2-肾上腺素受体、Gs 和腺苷酸环化酶之间的功能偶联完全丧失。因此,我们开发了一种基于正辛基-β-D-吡喃葡萄糖苷溶解的优化纯化方法,其中β 2-肾上腺素受体、Gs 和腺苷酸环化酶的功能特性在 CRLDF 中得以保留。使用这种方法,我们表明,异丙肾上腺素刺激的腺苷酸环化酶活性在 CRLDF 和过表达β 2-肾上腺素受体或β 2-肾上腺素受体-Gs 融合的 HEK-293 细胞的大块膜制剂中相似。相应地,用甲基-β-环糊精(一种 caveola 破坏剂)处理细胞不会影响β 2-肾上腺素受体诱导的 cAMP 反应。同样,这些反应对 caveolin 1 和 2 的过表达不敏感。另一方面,甲基-β-环糊精处理确实降低了β 2-肾上腺素受体诱导的 ERK 磷酸化。然而,甲基-β-环糊精的后一种作用可能归因于非特异性作用,而不是其破坏膜微区的能力。我们表明,定位在筏微区不会影响β 2-肾上腺素受体-Gs-腺苷酸环化酶途径的信号效率,并且甲基-β-环糊精可能通过直接影响信号系统而不是通过其 caveola 破坏特性来抑制信号。